SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003433
Filing Date
2021-03-24
Accepted
2021-03-24 17:16:48
Documents
73
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20201231x10k.htm   iXBRL 10-K 2338550
2 EX-4.3 tmb-20201231xex4d3.htm EX-4.3 65027
3 EX-23.1 tmb-20201231xex23d1.htm EX-23.1 3647
4 EX-31.1 tmb-20201231xex31d1.htm EX-31.1 15672
5 EX-31.2 tmb-20201231xex31d2.htm EX-31.2 15694
6 EX-32.1 tmb-20201231xex32d1.htm EX-32.1 7393
7 EX-32.2 tmb-20201231xex32d2.htm EX-32.2 7396
  Complete submission text file 0001558370-21-003433.txt   8803991

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20201231.xsd EX-101.SCH 62215
9 EX-101.CAL tmb-20201231_cal.xml EX-101.CAL 58808
10 EX-101.DEF tmb-20201231_def.xml EX-101.DEF 300004
11 EX-101.LAB tmb-20201231_lab.xml EX-101.LAB 465869
12 EX-101.PRE tmb-20201231_pre.xml EX-101.PRE 469014
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20201231x10k_htm.xml XML 1424623
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38191 | Film No.: 21769115
SIC: 2834 Pharmaceutical Preparations